JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehta, A. K.
Right arrow Articles by Ticku, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehta, A. K.
Right arrow Articles by Ticku, M. K.

Benzodiazepine and beta-carboline interactions with GABAA receptor- gated chloride channels in mammalian cultured spinal cord neurons

AK Mehta and MK Ticku

Department of Pharmacology, University of Texas Health Science Center, San Antonio.

The interaction of benzodiazepine (BZ) and beta carbolines with GABAA receptor-gated chloride channels using 36Cl influx biochemical functional assay in mammalian spinal cord cultured neurons was investigated. BZ-receptor agonists such as flunitrazepam, diazepam, clonazepam and flurazepam enhanced the effect of submaximal concentrations of GABA (10 microM)-stimulated 36Cl influx. The rank order of potencies was flunitrazepam greater than clonazepam greater than diazepam greater than flurazepam. In contrast, methyl-6,7- dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), ethyl-beta- carboline-3-carboxylate (beta-CCE), N-methyl-beta-carboline-3- carboxamide (FG 7142) and ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H- imidazo [1,5 alpha][1,4]-benzodiazepine-3-carboxylate (Ro 15-4513) inhibited GABA-stimulated 36Cl influx. The rank order of inhibitory potencies for the inverse agonists was DMCM greater than beta-CCE greater than Ro 15-4513 greater than FG 7142. Although lower concentrations of Ro 15-1788 antagonized the enhancement of BZ agonists like diazepam and the inhibition of inverse agonists like DMCM on GABA- stimulated 36Cl influx without exhibiting any effect per se, higher concentrations of Ro 15-1788 (greater than or equal to 10(-6) M) enhanced GABA-stimulated 36Cl influx. These observations indicate that flunitrazepam, diazepam, clonazepam and flurazepam are agonists; DMCM, beta-CCE, Ro 15-4513 and FG 7142 are inverse agonists, whereas Ro 15- 1788 is antagonist at lower concentrations and partial agonist at higher concentrations at the BZ receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 249, Issue 2, pp. 418-423, 05/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. R. McMahon, L. R. Gerak, and C. P. France
Efficacy and the Discriminative Stimulus Effects of Negative GABAA Modulators, or Inverse Agonists, in Diazepam-Treated Rhesus Monkeys
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 907 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. R. McMahon and C. P. France
Daily Treatment with Diazepam Differentially Modifies Sensitivity to the Effects of gamma -Aminobutyric AcidA Modulators on Schedule-Controlled Responding in Rhesus Monkeys
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1017 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. B. Williams and M. H. Akabas
Benzodiazepines Induce a Conformational Change in the Region of the gamma -Aminobutyric Acid Type A Receptor alpha 1-Subunit M3 Membrane-Spanning Segment
Mol. Pharmacol., November 1, 2000; 58(5): 1129 - 1136.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics.